Manufacturer record
Modern Laboratories 45-47: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Modern Laboratories 45-47 (Madhya Pradesh) were declared Not of Standard Quality between May 2020 and February 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
6 records linked to Modern Laboratories 45-47 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Vitamin B Complex Tablets N.F.I | VBT 2468Mfg 2024-05 · Exp 2026-04 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | VBT 2415Mfg 2024-03 · Exp 2026-02 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | VBT 2417Mfg 2024-03 · Exp 2026-02 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | VBT 2414Mfg 2024-03 · Exp 2026-02 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Vitamin B Complex Tablets N.F.I | VBT241 6Mfg 2024-03 · Exp 2026-02 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol.Other | DTL ThiruvananthapuramState lab | Feb 2025 |
| Metoclopramide Hydrochloride Injection IP 5 mg/ml | MEI1902Mfg 2019-05 · Exp 2021-04 | pHpH | RDTL ChandigarhCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.